E
Eero Vasar
Researcher at University of Tartu
Publications - 274
Citations - 7726
Eero Vasar is an academic researcher from University of Tartu. The author has contributed to research in topics: Receptor & Cholecystokinin. The author has an hindex of 43, co-authored 263 publications receiving 6930 citations. Previous affiliations of Eero Vasar include University of Copenhagen & Tallinn University of Technology.
Papers
More filters
Journal ArticleDOI
Wfs1‐deficient animals have brain‐region‐specific changes of Na+, K+‐ATPase activity and mRNA expression of α1 and β1 subunits
Silva Sütt,Alina Altpere,Riin Reimets,Tanel Visnapuu,Maarja Loomets,Sirli Raud,Tiit Salum,Riina Mahlapuu,Czeslava Kairane,Mihkel Zilmer,Eero Vasar +10 more
TL;DR: It is shown that Wfs1‐deficient mice have brain‐region‐specific changes in Na+,K+‐ATPase activity and in the expression of the α1 and β1 subunits, which is probably related to the dysfunction of ER stress regulation, which leads to cell apoptosis.
Journal ArticleDOI
Repeated Administration of D-Amphetamine Induces Distinct Alterations in Behavior and Metabolite Levels in 129Sv and Bl6 Mouse Strains.
Taavi Vanaveski,Jane Narvik,Jürgen Innos,Mari-Anne Philips,Aigar Ottas,Mario Plaas,Liina Haring,Liina Haring,Mihkel Zilmer,Eero Vasar +9 more
TL;DR: Pooled data from both strains showed that the elevation of isoleucine and leucine was a prominent biomarker of AMPH-induced behavioral sensitization, and Hexoses and kynurenine were reduced after repeated AMPH compared to saline in 129Sv.
Journal ArticleDOI
Cat odor exposure induces distinct changes in the exploratory behavior and Wfs1 gene expression in C57Bl/6 and 129Sv mice.
Sirli Raud,Silva Sütt,Mario Plaas,Hendrik Luuk,Jürgen Innos,Mari-Anne Philips,Sulev Kõks,Eero Vasar +7 more
TL;DR: Dynamics of Wfs1 gene expression and exploratory behavior suggest that the down-regulation of WFS1 gene in Bl6 mice might be related to the increased anxiety.
Journal ArticleDOI
Intracerebroventricular administration of cholecystokinin inhibits the activity of the dopaminergic and serotoninergic systems of the brain.
TL;DR: It can be assumed that cholecystokinin is an endogenous modulator of the activity of the monoaminergic systems of the brain.
Journal ArticleDOI
Variability in the effect of antidepressants upon Wfs1-deficient mice is dependent on the drugs’ mechanism of actions
Riin Reimets,Sirli Raud,Maarja Loomets,Tanel Visnapuu,Vallo Volke,Ain Reimets,Mario Plaas,Eero Vasar +7 more
TL;DR: The results of this study suggest that SSRIs are the drugs of choice for the treatment of depressive symptoms in diabetic patients and employing the mechanism of action of ketamine that affected glucose metabolism positively, could be an approach for development of improved antidepressants.